期刊文献+

Expression of Bmi-1,P16,and CD44v6 in Uterine Cervical Carcinoma and Its Clinical Significance 被引量:10

Expression of Bmi-1,P16,and CD44v6 in Uterine Cervical Carcinoma and Its Clinical Significance
暂未订购
导出
摘要 Objective Bmi-1, a putative proto-oncogene, is a core member of the polycomb gene family, which is expressed in many human tumors. The p16 protein negatively regulated cell proliferation, whereas CD44v6 is associated with proliferation as an important protein. Additionally, CD44v6 is an important nuclear antigen closely correlated to tumor metastasis. Tlle present study aims to investigate the expression and significance of Bmi-1, p16, and CD44v6 in uterine cervical carcinoma (UCC). Methods A total of 62 UCC, 30 cervical neoplasic, and 20 normal cervical mucosal tissues were used ill the current study. The expression of Bmi-1, p16, and CD44v6 in these tissues was determined using immunohistochemical assay. The relationships among the expression of these indices, the clinicopathologic features of UCC, and the survival rate of UCC patients were also discussed. The correlation between Bmi-1 protein expression and p16 or CD44v6 protein in UCC was analyzed. Results The expression of Bmi-l, p16, and CD44v6 was significantly high in cervical carcinoma compared with that in tlle cervical neoplasia and normal colorectal mucosa (P〈0.05). The over-expression of Bmi-1 protein in UCC was apparently related to the distant metastasis (P〈0.01) and the tumor, nodes and metastasis-classification, i.e. the TNM staging, World Health Organization (P〈0.05). Nevertheless, the positive expression of p16 protein in UCC was not significantly associated with the clinicopathologic features (P〉0.05). The Kaplan-Meier survival analysis showed that the over-expression of Bmi-1 significantly decreased the survival rate of UCC patients (P〈0.05). A strong correlation indicated that there was statistical significance between the expression of Bmi-1 and CD44V6 proteins in UCC (r=0.419, P=0.001). Conclusions The over-expression of Bmi-1 and CD44v6 protein closely correlate to the tumorigenesis, metastasis, and prognosis of UCC. Bmi-I and CD44v6 may be used to predict the prognosis of cervical carcinoma. Bmi-1 may indirectly regulate the expression of CD44v6 in UCC patients. The positive expression of p16 protein is possibly associated with the tumorigenesis, but not with the metastasis or prognosis of UCC. Objective Bmi-1,a putative proto-oncogene,is a core member of the polycomb gene family,which is expressed in many human tumors.The pl6 protein negatively regulated cell proliferation,whereas CD44v6 is associated with proliferation as an important protein.Additionally,CD44v6 is an important nuclear antigen closely correlated to tumor metastasis.The present study aims to investigate the expression and significance of Bmi-1,pl6,and CD44v6 in uterine cervical carcinoma(UCC). Methods A total of 62 UCC,30 cervical neoplasic,and 20 normal cervical mucosal tissues were used in the current study.The expression of Bmi-1,pl6,and CD44v6 in these tissues was determined using immunohistochemical assay.The relationships among the expression of these indices,the clinicopathologic features of UCC,and the survival rate of UCC patients were also discussed.The correlation between Bmi-1 protein expression and pl6 or CD44v6 protein in UCC was analyzed. Results The expression of Bmi-1,p16,and CD44v6 was significantly high in cervical carcinoma compared with that in the cervical neoplasia and normal colorectal mucosa(P<0.05).The over-expression of Bmi-1 protein in UCC was apparently related to the distant metastasis(P<0.01) and the tumor,nodes and metastasis-classification,i.e.the TNM staging,World Health Organization(P<0.05). Nevertheless,the positive expression of pl6 protein in UCC was not significantly associated with the clinicopathologic features (P>0.05).The Kaplan-Meier survival analysis showed that the over-expression of Bmi-1 significantly decreased the survival rate of UCC patients(P<0.05).A strong correlation indicated that there was statistical significance between the expression of Bmi-1 and CD44V6 proteins in UCC(r=0.419,P<0.001). Conclusions The over-expression of Bmi-1 and CD44v6 protein closely correlate to the tumorigenesis,metastasis,and prognosis of UCC.Bmi-1 and CD44v6 may be used to predict the prognosis of cervical carcinoma.Bmi-1 may indirectly regulate the expression of CD44v6 in UCC patients.The positive expression of p16 protein is possibly associated with the tumorigenesis,but not with the metastasis or prognosis of UCC.
出处 《Clinical Oncology and Cancer Research》 CAS CSCD 2012年第1期48-53,共6页 临床肿瘤与癌症研究(英文版)
基金 supported by a grant from the Social Development Projects of Guangdong Sci-Tech Planning(No. 2010B031600201)
关键词 Bmi-1 protein P16 protein CD44V6 uterine cervical carcinoma IMMUNOHISTOCHEMISTRY 临床意义 P16 宫颈癌 肿瘤转移 过度表达 世界卫生组织 UCC 蛋白质
  • 相关文献

参考文献12

  • 1Cao R,Tsukada Y,Zhang Y. Role of Bmi-1 and Ring1A in H2A ubiquitylation and Hox gene silencing[J].Molecules and Cells,2005.845-854.
  • 2Haupt Y,Alexander WS,Barri G. Novel zinc fin-gergene implicated asmyc collaboratorby retrovirally ac-celerated lymphomagenesis in Eμ-myctransgenic mice[J].Cell,1991.753-763.
  • 3Kikuchi J,Kinoshita I,Shimizu Y. Distinctive expression of the polycomb group proteins Bmi1 polycomb ring finger oncogene and enhancer of zeste homolog 2 in nonsmall cell lung cancers and their clinical and clinicopathologic significance[J].Cancer,2010.3015-3024.doi:10.1002/cncr.25128.
  • 4Li DW,Tang HM,Fan JW. Expression level of Bmi-1 oncoprotein is associated with progression and prognosis in colon cancer[J].Journal of Cancer Research and Clinical Oncology,2010.997-1006.
  • 5Honig A,Weidler C,H(a)usler S. Overexpression of polycomb protein BMI-1 in human specimens of breast,ovarian,endometrial and cervical cancer[J].Anticancer Research,2010.1559-1564.
  • 6Guo BH,Feng Y,Zhang R. Bmi-1 promotes invasion and metastasis,and its elevated expression is correlated with anadvanced stage of breast cancer[J].Molecular Cancer Therapeutics,2011.10.
  • 7Song LB,Zeng MS,LiaoWT. Bmi-1 is a novel molecular marker of nasopharyngeal carcinoma progression andimmortalizes primary human nasopharyngeal epithelial cells[J].Cancer Research,2006.6225-6232.
  • 8Huang KH,Liu JH,Song LB. Bmi-1 expression predicts prognosis for patients with gastric carcinoma[J].Journal of Surgical Oncology,2008.267-272.
  • 9Liggett WH Jr,Sidransky D. Role of the p16 tumor suppressor gene in cancer[J].Journal of Clinical Oncology,1998.1197-1206.
  • 10Kawano T,Yanoma S,Nakamura Y. Evaluation of soluble adhesion molecules CD44 (CD44 st,CD44 v5,CD44 v6),ICAM21,and VCAM21 as tumor markers in head and neck cancer[J].American Journal of Otolaryngology,2005,(5):308-313.doi:10.1016/j.amjoto.2005.02.005.

同被引文献57

引证文献10

二级引证文献36

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部